IPCA Laboratories
Madhura Powale is a Senior Business Development Executive at Ipca Laboratories Limited since November 2024. Previously, Madhura held the position of Business Development Executive at Harman Finochem Ltd, focusing on International Business Development from July 2023 to December 2024. Madhura's early career includes roles as Business Development Executive and Management Trainee at LYRUS LIFE SCIENCES PVT LTD from July 2021 to July 2023, and as a Management Trainee at Rusan Health Care Pvt Ltd in 2019. Additionally, Madhura completed a Summer Internship at RPG Life Sciences Ltd in 2018. Madhura holds a B. Pharma and MBA in Pharmaceutical Marketing and Management from SVKM's Narsee Monjee Institute of Management Studies (NMIMS), graduated in 2020.
This person is not in any teams
IPCA Laboratories
3 followers
Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is focused on cardio-diabetic market. The Company's activa division serves the rheumatology market. Its altus division caters to the needs of intensivists, both surgical and non-surgical. Its Bionova division's focus area is dermatology. Its dynamix division focuses on cardiovascular, gastro-intestinal, anti-bacterial, pain management and respiratory sectors. It hycare division caters to the needs of cardiologists and diabetologists. Its divisions also include innova, intima, pain management, pharma and uro sciences.